Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-139-5p ABCA1 0.65 0 0.02 0.83411 miRanda -0.26 0 NA
2 hsa-miR-330-3p ABCA1 0.43 0.003 0.02 0.83411 miRNATAP -0.16 0 NA
3 hsa-miR-338-3p ABCA1 0.4 0.00344 0.02 0.83411 miRanda -0.2 0 NA
4 hsa-miR-338-5p ABCA1 0.42 0.00246 0.02 0.83411 mirMAP -0.12 0 NA
5 hsa-miR-490-3p ABCA1 0.83 1.0E-5 0.02 0.83411 miRanda -0.15 0 NA
6 hsa-miR-139-5p ABCA13 0.65 0 -0.77 0 miRanda -0.35 0 NA
7 hsa-miR-338-3p ABCA13 0.4 0.00344 -0.77 0 miRanda -0.22 0.00016 NA
8 hsa-miR-490-3p ABCA13 0.83 1.0E-5 -0.77 0 miRanda -0.12 0.00213 NA
9 hsa-miR-139-5p ABCB4 0.65 0 -0.62 0 miRanda -0.28 0 NA
10 hsa-miR-129-5p ABCD1 0.57 0.00116 -0.29 0 MirTarget -0.14 0 NA
11 hsa-miR-330-3p ABHD4 0.43 0.003 0.07 0.29216 PITA; miRNATAP -0.11 0 NA
12 hsa-miR-338-3p ABHD4 0.4 0.00344 0.07 0.29216 miRanda -0.11 0 NA
13 hsa-miR-139-5p ABI3BP 0.65 0 0.53 0.00051 miRanda -0.12 0.01413 NA
14 hsa-miR-139-5p ACCS 0.65 0 -0.41 0.00105 miRanda -0.15 0.00021 NA
15 hsa-miR-129-5p ADAM12 0.57 0.00116 -1.04 0 miRanda; mirMAP -0.18 0 NA
16 hsa-miR-139-5p ADAM12 0.65 0 -1.04 0 miRanda -0.3 0 NA
17 hsa-miR-338-3p ADAM12 0.4 0.00344 -1.04 0 miRanda -0.16 0.0022 NA
18 hsa-miR-338-3p ADAM17 0.4 0.00344 -0.12 0.04723 PITA; miRanda; miRNATAP -0.12 0 26617808 MiR 338 3p inhibits the proliferation and migration of gastric cancer cells by targeting ADAM17; Moreover we identified A disintegrin and metalloproteinase 17 ADAM17 gene as potential target of miR-338-3p; Importantly ADAM17 rescued the miR-338-3p mediated inhibition of cell proliferation migration and invasion; Our study suggested that miR-338-3p is significantly decreased in gastric cancer and inhibits cell proliferation migration and invasion partially via the downregulation of ADAM17
19 hsa-miR-330-5p ADAM29 0.26 0.04652 0.97 0 miRanda -0.12 0.04745 NA
20 hsa-miR-490-3p ADAM6 0.83 1.0E-5 -0.77 0.0008 miRanda -0.29 0 NA
21 hsa-miR-338-5p ADAMDEC1 0.42 0.00246 -1.49 0 MirTarget -0.24 0.00255 NA
22 hsa-miR-330-5p ADAMTS13 0.26 0.04652 0.19 0.01274 miRanda -0.11 2.0E-5 NA
23 hsa-miR-490-3p ADAMTS20 0.83 1.0E-5 0.74 0.00388 miRanda -0.17 0.00632 NA
24 hsa-miR-330-3p ADAMTS5 0.43 0.003 0.25 0.0171 miRNATAP -0.18 0 NA
25 hsa-miR-139-5p ADAMTS6 0.65 0 -0.12 0.24023 miRanda -0.17 0 NA
26 hsa-miR-330-3p ADAMTS6 0.43 0.003 -0.12 0.24023 PITA; mirMAP -0.26 0 NA
27 hsa-miR-330-5p ADAMTS6 0.26 0.04652 -0.12 0.24023 PITA; miRanda; miRNATAP -0.31 0 NA
28 hsa-miR-338-3p ADAMTS6 0.4 0.00344 -0.12 0.24023 miRNATAP -0.21 0 NA
29 hsa-miR-129-5p ADAMTS7 0.57 0.00116 -0.77 0 MirTarget -0.17 0 NA
30 hsa-miR-139-5p ADAMTS9 0.65 0 0.11 0.31553 miRanda -0.18 0 NA
31 hsa-miR-338-3p ADAMTSL1 0.4 0.00344 0.01 0.96773 miRanda -0.11 0.01875 NA
32 hsa-miR-490-3p ADAMTSL4 0.83 1.0E-5 -0.59 0 miRanda -0.11 3.0E-5 NA
33 hsa-miR-338-5p ADM 0.42 0.00246 -0.51 0.00045 MirTarget; PITA; miRNATAP -0.14 0.00198 NA
34 hsa-miR-330-5p ADM2 0.26 0.04652 -0.69 0 mirMAP -0.13 0.00403 NA
35 hsa-miR-490-3p AEN 0.83 1.0E-5 -0.53 0 mirMAP -0.1 0 NA
36 hsa-miR-330-3p AFAP1 0.43 0.003 0.07 0.32292 mirMAP -0.1 0 NA
37 hsa-miR-139-5p AFAP1L1 0.65 0 -0.69 0 miRanda -0.17 0 NA
38 hsa-miR-129-5p AGER 0.57 0.00116 0.05 0.58371 MirTarget -0.11 0 NA
39 hsa-miR-139-5p AHR 0.65 0 -0.15 0.14317 miRanda -0.1 0.00309 NA
40 hsa-miR-338-3p AIM1 0.4 0.00344 -0.76 0 miRanda -0.16 0.00048 NA
41 hsa-miR-338-3p AIM2 0.4 0.00344 0.11 0.31234 miRanda -0.19 0 NA
42 hsa-miR-129-5p AK2 0.57 0.00116 -0.28 1.0E-5 miRanda -0.1 0 NA
43 hsa-miR-139-5p AKAP13 0.65 0 -0.09 0.14298 miRanda -0.12 0 NA
44 hsa-miR-129-5p AKNAD1 0.57 0.00116 -0.78 0 miRanda -0.14 0.00011 NA
45 hsa-miR-330-3p ALDH1L2 0.43 0.003 0.25 0.00714 MirTarget; mirMAP -0.11 2.0E-5 NA
46 hsa-miR-330-5p ALDH1L2 0.26 0.04652 0.25 0.00714 MirTarget; miRanda -0.11 0.00033 NA
47 hsa-miR-485-3p ALDH1L2 0.53 0.00149 0.25 0.00714 mirMAP -0.13 0 NA
48 hsa-miR-129-5p ALDH3B1 0.57 0.00116 -0.3 0.00016 miRanda -0.11 0 NA
49 hsa-miR-139-5p ALOX5 0.65 0 -0.34 0.00383 miRanda -0.25 0 NA
50 hsa-miR-490-3p ALPK2 0.83 1.0E-5 -0.93 0 miRanda -0.15 0.00028 NA
51 hsa-miR-139-5p AMMECR1 0.65 0 -0.11 0.0201 miRanda -0.12 0 NA
52 hsa-miR-129-5p ANGPT2 0.57 0.00116 -0.97 0 MirTarget; miRanda -0.32 0 NA
53 hsa-miR-138-5p ANGPT2 0.62 1.0E-5 -0.97 0 MirTarget -0.29 0 NA
54 hsa-miR-330-5p ANKRD13B 0.26 0.04652 0.09 0.14467 miRanda; miRNATAP -0.11 0 NA
55 hsa-miR-330-5p ANKS3 0.26 0.04652 0.02 0.7675 miRNATAP -0.12 0 NA
56 hsa-miR-330-5p ANKZF1 0.26 0.04652 0.02 0.75315 miRanda -0.14 0 NA
57 hsa-miR-138-1-3p ANO6 0.45 0.0006 -0.36 1.0E-5 MirTarget -0.13 0 NA
58 hsa-miR-138-5p ANO6 0.62 1.0E-5 -0.36 1.0E-5 MirTarget -0.22 0 NA
59 hsa-miR-485-3p ANO6 0.53 0.00149 -0.36 1.0E-5 MirTarget -0.12 0 NA
60 hsa-miR-129-5p ANTXR1 0.57 0.00116 -0.06 0.43139 miRanda; mirMAP -0.11 0 NA
61 hsa-miR-338-3p ANTXR1 0.4 0.00344 -0.06 0.43139 miRanda -0.17 0 NA
62 hsa-miR-129-5p ANTXR2 0.57 0.00116 -0.43 0 miRanda; miRNATAP -0.12 0 NA
63 hsa-miR-490-3p ANTXR2 0.83 1.0E-5 -0.43 0 PITA -0.11 0 NA
64 hsa-miR-338-3p ANXA1 0.4 0.00344 -1.31 0 miRanda -0.13 0.03834 NA
65 hsa-miR-139-5p APBB1IP 0.65 0 -0.12 0.32514 miRanda -0.22 0 NA
66 hsa-miR-139-5p APH1A 0.65 0 -0.14 0.00502 miRanda -0.12 0 NA
67 hsa-miR-139-5p APOBEC3D 0.65 0 -0.65 0 miRanda -0.2 0 NA
68 hsa-miR-490-3p APOL1 0.83 1.0E-5 -0.6 0 miRanda -0.14 0 NA
69 hsa-miR-139-5p APOL4 0.65 0 -1.31 0 mirMAP -0.5 0 NA
70 hsa-miR-139-5p AQP1 0.65 0 -0.78 3.0E-5 miRanda -0.14 0.02522 NA
71 hsa-miR-338-3p AR 0.4 0.00344 -0.15 0.36469 miRanda -0.23 7.0E-5 NA
72 hsa-miR-129-5p ARHGAP11A 0.57 0.00116 -1.03 0 miRanda -0.14 0 NA
73 hsa-miR-139-5p ARHGAP18 0.65 0 -0.46 0 miRanda -0.21 0 NA
74 hsa-miR-338-3p ARHGAP18 0.4 0.00344 -0.46 0 miRanda -0.14 1.0E-5 NA
75 hsa-miR-338-5p ARHGAP18 0.42 0.00246 -0.46 0 PITA; mirMAP -0.11 0.00016 NA
76 hsa-miR-338-3p ARHGAP31 0.4 0.00344 0.11 0.1708 miRanda -0.11 0 NA
77 hsa-miR-138-5p ARHGAP42 0.62 1.0E-5 0.07 0.38162 MirTarget; miRNATAP -0.16 0 NA
78 hsa-miR-338-3p ARHGEF10L 0.4 0.00344 0.15 0.04581 PITA; miRanda; miRNATAP -0.1 1.0E-5 NA
79 hsa-miR-139-5p ARHGEF6 0.65 0 0.12 0.11307 miRanda -0.14 0 NA
80 hsa-miR-139-5p ARID3B 0.65 0 -0.1 0.03142 miRanda -0.1 0 NA
81 hsa-miR-129-5p ARL11 0.57 0.00116 -0.29 0.00363 miRanda; mirMAP -0.14 0 NA
82 hsa-miR-490-3p ARL11 0.83 1.0E-5 -0.29 0.00363 miRanda -0.14 0 NA
83 hsa-miR-139-5p ARL6IP6 0.65 0 -0.05 0.29247 miRanda -0.12 0 NA
84 hsa-miR-129-5p ARPC1B 0.57 0.00116 -0.33 0.00019 mirMAP -0.13 0 NA
85 hsa-miR-138-5p ARRDC3 0.62 1.0E-5 -0.12 0.04815 miRNATAP -0.14 0 NA
86 hsa-miR-330-5p ARVCF 0.26 0.04652 0.13 0.01897 MirTarget -0.1 0 NA
87 hsa-miR-330-5p ASF1B 0.26 0.04652 -1.4 0 miRanda -0.22 0 NA
88 hsa-miR-490-3p ASF1B 0.83 1.0E-5 -1.4 0 miRanda -0.25 0 NA
89 hsa-miR-129-5p ASPN 0.57 0.00116 -0.54 2.0E-5 miRanda -0.1 0.00189 NA
90 hsa-miR-139-5p ASPN 0.65 0 -0.54 2.0E-5 miRanda -0.17 4.0E-5 NA
91 hsa-miR-330-5p ATAD2B 0.26 0.04652 -0.07 0.17656 PITA; miRanda -0.12 0 NA
92 hsa-miR-338-3p ATAD2B 0.4 0.00344 -0.07 0.17656 miRanda -0.11 0 NA
93 hsa-miR-139-5p ATF3 0.65 0 -0.72 0 miRanda -0.14 0.00021 NA
94 hsa-miR-338-3p ATP10D 0.4 0.00344 -0.15 0.01894 MirTarget; miRanda -0.11 0 NA
95 hsa-miR-139-5p ATP6V0A2 0.65 0 -0.14 0.00239 miRanda -0.1 0 NA
96 hsa-miR-338-3p ATP6V1B1 0.4 0.00344 -0.14 0.26945 miRanda -0.19 1.0E-5 NA
97 hsa-miR-139-5p B3GALNT2 0.65 0 -0.26 0 MirTarget; miRanda -0.11 0 NA
98 hsa-miR-330-3p BARD1 0.43 0.003 -0.46 0.0001 MirTarget; mirMAP -0.12 0.00121 NA
99 hsa-miR-338-5p BARD1 0.42 0.00246 -0.46 0.0001 mirMAP -0.12 0.00183 NA
100 hsa-miR-490-3p BATF2 0.83 1.0E-5 -0.48 0 MirTarget; miRanda -0.16 0 NA
101 hsa-miR-129-5p BAZ1A 0.57 0.00116 -0.31 1.0E-5 miRanda -0.14 0 NA
102 hsa-miR-139-5p BAZ1A 0.65 0 -0.31 1.0E-5 miRanda -0.2 0 NA
103 hsa-miR-330-5p BAZ1A 0.26 0.04652 -0.31 1.0E-5 miRanda -0.19 0 NA
104 hsa-miR-338-3p BAZ1A 0.4 0.00344 -0.31 1.0E-5 miRanda -0.16 0 NA
105 hsa-miR-129-5p BCHE 0.57 0.00116 0.09 0.28367 PITA; miRanda -0.13 0 NA
106 hsa-miR-139-5p BCHE 0.65 0 0.09 0.28367 miRanda -0.11 1.0E-5 NA
107 hsa-miR-129-5p BCL2L12 0.57 0.00116 -0.6 0 miRanda -0.17 0 NA
108 hsa-miR-330-5p BCL3 0.26 0.04652 -0.49 0 MirTarget; miRanda -0.11 4.0E-5 NA
109 hsa-miR-330-5p BEND3 0.26 0.04652 -0.15 0.00633 miRanda -0.1 0 NA
110 hsa-miR-330-5p BEND7 0.26 0.04652 0.12 0.05179 miRanda -0.18 0 NA
111 hsa-miR-129-5p BEST3 0.57 0.00116 0.16 0.28659 MirTarget; miRanda -0.18 0 NA
112 hsa-miR-490-3p BEST3 0.83 1.0E-5 0.16 0.28659 miRanda -0.18 0 NA
113 hsa-miR-338-3p BIRC5 0.4 0.00344 -1.68 0 miRanda -0.24 0.00039 NA
114 hsa-miR-330-3p BMF 0.43 0.003 -0.43 1.0E-5 mirMAP -0.2 0 NA
115 hsa-miR-330-5p BMF 0.26 0.04652 -0.43 1.0E-5 mirMAP -0.23 0 NA
116 hsa-miR-139-5p BMP1 0.65 0 -0.3 0 miRanda -0.2 0 NA
117 hsa-miR-139-5p BNIP2 0.65 0 -0.11 0.00825 miRanda -0.12 0 NA
118 hsa-miR-139-5p BOC 0.65 0 -0.23 0.00885 miRanda -0.11 3.0E-5 NA
119 hsa-miR-330-5p BOC 0.26 0.04652 -0.23 0.00885 miRanda -0.18 0 NA
120 hsa-miR-338-3p BOC 0.4 0.00344 -0.23 0.00885 miRanda -0.16 0 NA
121 hsa-miR-338-5p BOC 0.42 0.00246 -0.23 0.00885 MirTarget; PITA; miRNATAP -0.15 0 NA
122 hsa-miR-129-5p BRCA2 0.57 0.00116 -1.03 0 miRanda; mirMAP -0.16 0 NA
123 hsa-miR-490-3p BRIP1 0.83 1.0E-5 -1.32 0 miRanda -0.12 0.00106 NA
124 hsa-miR-139-5p BST1 0.65 0 -0.48 0 miRanda -0.27 0 NA
125 hsa-miR-490-3p BST1 0.83 1.0E-5 -0.48 0 miRanda -0.13 0 NA
126 hsa-miR-138-5p BTG1 0.62 1.0E-5 -0.18 0.00164 miRNATAP -0.13 0 NA
127 hsa-miR-330-3p BTG1 0.43 0.003 -0.18 0.00164 PITA; miRNATAP -0.15 0 NA
128 hsa-miR-338-3p BTG1 0.4 0.00344 -0.18 0.00164 miRanda -0.14 0 NA
129 hsa-miR-139-5p BTG3 0.65 0 -0.43 0 MirTarget; PITA; miRanda; miRNATAP -0.22 0 NA
130 hsa-miR-338-5p BTG3 0.42 0.00246 -0.43 0 MirTarget; PITA; miRNATAP -0.11 0 NA
131 hsa-miR-129-5p BTN2A2 0.57 0.00116 -0.55 0 miRanda -0.11 0 NA
132 hsa-miR-338-3p BTN2A2 0.4 0.00344 -0.55 0 miRanda -0.16 0 NA
133 hsa-miR-490-3p BTN2A2 0.83 1.0E-5 -0.55 0 miRanda -0.13 0 NA
134 hsa-miR-139-5p BTN3A1 0.65 0 -0.28 2.0E-5 miRanda -0.14 0 NA
135 hsa-miR-139-5p BUB1 0.65 0 -1.44 0 miRanda -0.36 0 NA
136 hsa-miR-338-3p C15orf39 0.4 0.00344 0.13 0.07586 mirMAP -0.1 2.0E-5 NA
137 hsa-miR-330-3p C16orf87 0.43 0.003 -0.11 0.02794 mirMAP -0.12 0 NA
138 hsa-miR-485-3p C16orf87 0.53 0.00149 -0.11 0.02794 mirMAP -0.1 0 NA
139 hsa-miR-330-3p C17orf53 0.43 0.003 -0.61 0 miRNATAP -0.14 0 NA
140 hsa-miR-330-5p C1QTNF6 0.26 0.04652 -0.32 1.0E-5 miRanda -0.14 0 NA
141 hsa-miR-490-3p C1QTNF6 0.83 1.0E-5 -0.32 1.0E-5 miRanda -0.15 0 NA
142 hsa-miR-129-5p C1R 0.57 0.00116 -0.78 0 MirTarget; mirMAP -0.18 0 NA
143 hsa-miR-129-5p C1S 0.57 0.00116 -0.57 0 MirTarget -0.12 9.0E-5 NA
144 hsa-miR-330-5p C1orf106 0.26 0.04652 -0.17 0.09695 miRNATAP -0.19 0 NA
145 hsa-miR-129-5p C2 0.57 0.00116 -0.51 3.0E-5 miRanda -0.16 0 NA
146 hsa-miR-330-3p C2orf68 0.43 0.003 -0.04 0.40454 mirMAP -0.11 0 NA
147 hsa-miR-129-5p C5AR1 0.57 0.00116 -0.4 0.0018 miRanda -0.17 0 NA
148 hsa-miR-129-5p CA12 0.57 0.00116 -0.11 0.46148 miRanda; mirMAP -0.11 0.00278 NA
149 hsa-miR-138-5p CA3 0.62 1.0E-5 -1.27 0 MirTarget -0.27 0 NA
150 hsa-miR-129-5p CACNA2D4 0.57 0.00116 -0.12 0.22376 miRanda; mirMAP -0.16 0 NA
NumGOOverlapSizeP ValueAdj. P Value
1 REGULATION OF CELL PROLIFERATION 220 1496 6.212e-36 2.891e-32
2 IMMUNE SYSTEM PROCESS 258 1984 3.053e-33 6.576e-30
3 TISSUE DEVELOPMENT 216 1518 4.24e-33 6.576e-30
4 ORGAN MORPHOGENESIS 140 841 4.707e-28 5.476e-25
5 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 229 1805 1.073e-27 9.986e-25
6 POSITIVE REGULATION OF GENE EXPRESSION 222 1733 2.173e-27 1.685e-24
7 EMBRYO DEVELOPMENT 142 894 2.513e-26 1.671e-23
8 EMBRYONIC MORPHOGENESIS 103 539 1.562e-25 9.087e-23
9 SKELETAL SYSTEM DEVELOPMENT 93 455 2.402e-25 1.242e-22
10 POSITIVE REGULATION OF CELL PROLIFERATION 131 814 7.571e-25 3.523e-22
11 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 147 1004 1.385e-23 5.857e-21
12 TUBE DEVELOPMENT 100 552 5.558e-23 2.155e-20
13 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 181 1395 8.181e-23 2.928e-20
14 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 218 1848 3.9e-22 1.283e-19
15 EMBRYONIC ORGAN DEVELOPMENT 82 406 4.137e-22 1.283e-19
16 BIOLOGICAL ADHESION 145 1032 1.617e-21 4.703e-19
17 REGULATION OF CELL DIFFERENTIATION 186 1492 1.861e-21 5.094e-19
18 EMBRYONIC ORGAN MORPHOGENESIS 65 279 3.427e-21 8.597e-19
19 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 210 1784 3.511e-21 8.597e-19
20 EXTRACELLULAR STRUCTURE ORGANIZATION 68 304 4.569e-21 1.063e-18
21 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 200 1672 5.87e-21 1.301e-18
22 EPITHELIUM DEVELOPMENT 135 945 1.042e-20 2.205e-18
23 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 96 554 1.122e-20 2.27e-18
24 TISSUE MORPHOGENESIS 93 533 2.858e-20 5.541e-18
25 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 150 1142 2.059e-19 3.831e-17
26 SINGLE ORGANISM CELL ADHESION 83 459 3.47e-19 6.21e-17
27 RESPONSE TO EXTERNAL STIMULUS 207 1821 4.378e-19 7.544e-17
28 RESPONSE TO LIPID 125 888 1.106e-18 1.837e-16
29 POSITIVE REGULATION OF RESPONSE TO STIMULUS 214 1929 1.689e-18 2.709e-16
30 TUBE MORPHOGENESIS 66 323 2.714e-18 4.21e-16
31 NEGATIVE REGULATION OF GENE EXPRESSION 177 1493 3.996e-18 5.998e-16
32 VASCULATURE DEVELOPMENT 82 469 4.752e-18 6.909e-16
33 CARDIOVASCULAR SYSTEM DEVELOPMENT 114 788 5.268e-18 7.209e-16
34 CIRCULATORY SYSTEM DEVELOPMENT 114 788 5.268e-18 7.209e-16
35 MORPHOGENESIS OF AN EPITHELIUM 74 400 8.49e-18 1.129e-15
36 IMMUNE RESPONSE 142 1100 9.85e-18 1.273e-15
37 GLAND DEVELOPMENT 73 395 1.51e-17 1.899e-15
38 REGULATION OF IMMUNE SYSTEM PROCESS 167 1403 2.818e-17 3.45e-15
39 IMMUNE SYSTEM DEVELOPMENT 92 582 3.691e-17 4.403e-15
40 REGULATION OF CELL ADHESION 96 629 7.864e-17 9.147e-15
41 DEFENSE RESPONSE 151 1231 8.359e-17 9.486e-15
42 BLOOD VESSEL MORPHOGENESIS 68 364 1.119e-16 1.24e-14
43 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 37 122 1.366e-16 1.478e-14
44 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 126 957 1.787e-16 1.89e-14
45 REGULATION OF CELL DEATH 170 1472 2.571e-16 2.658e-14
46 SENSORY ORGAN DEVELOPMENT 81 493 3.236e-16 3.274e-14
47 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 127 983 5.937e-16 5.878e-14
48 LEUKOCYTE CELL CELL ADHESION 54 255 6.77e-16 6.562e-14
49 PATTERN SPECIFICATION PROCESS 72 418 1.227e-15 1.165e-13
50 CELL ACTIVATION 87 568 1.911e-15 1.778e-13
51 NEGATIVE REGULATION OF CELL PROLIFERATION 94 643 2.69e-15 2.454e-13
52 RESPONSE TO ENDOGENOUS STIMULUS 165 1450 2.939e-15 2.63e-13
53 UROGENITAL SYSTEM DEVELOPMENT 58 299 3.652e-15 3.206e-13
54 POSITIVE REGULATION OF CELL DIFFERENTIATION 110 823 6.136e-15 5.287e-13
55 RESPONSE TO BIOTIC STIMULUS 115 886 1.153e-14 9.753e-13
56 RESPONSE TO OXYGEN CONTAINING COMPOUND 157 1381 1.667e-14 1.385e-12
57 ANTERIOR POSTERIOR PATTERN SPECIFICATION 44 194 2.548e-14 2.08e-12
58 MITOTIC CELL CYCLE 103 766 3.215e-14 2.58e-12
59 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 99 724 3.636e-14 2.868e-12
60 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 167 1517 3.827e-14 2.968e-12
61 SENSORY ORGAN MORPHOGENESIS 49 239 5.639e-14 4.301e-12
62 LEUKOCYTE ACTIVATION 68 414 8.439e-14 6.333e-12
63 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 111 867 8.796e-14 6.497e-12
64 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 58 321 9.285e-14 6.75e-12
65 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 105 801 9.477e-14 6.784e-12
66 RESPONSE TO MECHANICAL STIMULUS 45 210 1.15e-13 8.104e-12
67 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 29 93 1.186e-13 8.233e-12
68 RESPONSE TO ORGANIC CYCLIC COMPOUND 115 917 1.266e-13 8.611e-12
69 LOCOMOTION 132 1114 1.277e-13 8.611e-12
70 LYMPHOCYTE ACTIVATION 60 342 1.333e-13 8.858e-12
71 RESPONSE TO WOUNDING 82 563 2.133e-13 1.398e-11
72 CELL CELL ADHESION 86 608 2.867e-13 1.853e-11
73 RESPONSE TO GROWTH FACTOR 73 475 3.19e-13 2.033e-11
74 EAR DEVELOPMENT 42 195 6.324e-13 3.977e-11
75 INFLAMMATORY RESPONSE 70 454 8.455e-13 5.245e-11
76 CELL CYCLE 146 1316 1.069e-12 6.544e-11
77 REGULATION OF EPITHELIAL CELL PROLIFERATION 52 285 1.211e-12 7.32e-11
78 MORPHOGENESIS OF A BRANCHING STRUCTURE 38 167 1.329e-12 7.926e-11
79 CONNECTIVE TISSUE DEVELOPMENT 41 194 2.289e-12 1.348e-10
80 POSITIVE REGULATION OF CELL COMMUNICATION 162 1532 2.82e-12 1.64e-10
81 REGULATION OF IMMUNE RESPONSE 106 858 3.162e-12 1.816e-10
82 CELL CYCLE PROCESS 125 1081 3.347e-12 1.899e-10
83 REGIONALIZATION 54 311 3.431e-12 1.923e-10
84 CELL DEVELOPMENT 153 1426 4.056e-12 2.246e-10
85 CELL MOTILITY 103 835 7.187e-12 3.844e-10
86 LOCALIZATION OF CELL 103 835 7.187e-12 3.844e-10
87 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 140 1275 7.071e-12 3.844e-10
88 SKELETAL SYSTEM MORPHOGENESIS 41 201 7.641e-12 4.04e-10
89 RESPONSE TO CYTOKINE 92 714 9.277e-12 4.796e-10
90 T CELL DIFFERENTIATION 31 123 9.206e-12 4.796e-10
91 REGULATION OF CELLULAR COMPONENT MOVEMENT 97 771 9.872e-12 5.048e-10
92 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 32 131 1.053e-11 5.325e-10
93 REGULATION OF CYTOKINE PRODUCTION 78 563 1.092e-11 5.464e-10
94 CARTILAGE DEVELOPMENT 34 147 1.238e-11 6.056e-10
95 ANGIOGENESIS 51 293 1.249e-11 6.056e-10
96 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 94 740 1.224e-11 6.056e-10
97 POSITIVE REGULATION OF CYTOKINE PRODUCTION 59 370 1.342e-11 6.438e-10
98 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 118 1021 1.481e-11 7.029e-10
99 CELL SUBSTRATE ADHESION 36 164 1.573e-11 7.392e-10
100 RESPONSE TO ALCOHOL 58 362 1.645e-11 7.656e-10
101 HEART DEVELOPMENT 68 466 2.337e-11 1.077e-09
102 POSITIVE REGULATION OF CELL DEATH 81 605 2.515e-11 1.147e-09
103 APPENDAGE DEVELOPMENT 36 169 3.928e-11 1.757e-09
104 LIMB DEVELOPMENT 36 169 3.928e-11 1.757e-09
105 GROWTH 62 410 4.026e-11 1.784e-09
106 REGULATION OF OSSIFICATION 37 178 4.49e-11 1.971e-09
107 DEVELOPMENTAL GROWTH 54 333 5.19e-11 2.257e-09
108 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 154 1492 6.625e-11 2.854e-09
109 WOUND HEALING 67 470 9.292e-11 3.967e-09
110 EAR MORPHOGENESIS 28 112 1.138e-10 4.814e-09
111 RESPONSE TO BACTERIUM 72 528 1.441e-10 6.041e-09
112 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 96 799 1.663e-10 6.909e-09
113 CELL DEATH 113 1001 1.748e-10 7.199e-09
114 REGULATION OF EMBRYONIC DEVELOPMENT 28 114 1.78e-10 7.266e-09
115 NEGATIVE REGULATION OF CELL DIFFERENTIATION 79 609 2.09e-10 8.456e-09
116 REPRODUCTIVE SYSTEM DEVELOPMENT 60 408 2.603e-10 1.044e-08
117 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 113 1008 2.659e-10 1.057e-08
118 REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 25 94 2.704e-10 1.066e-08
119 DIGESTIVE SYSTEM DEVELOPMENT 32 148 3.168e-10 1.239e-08
120 RESPONSE TO ABIOTIC STIMULUS 114 1024 3.343e-10 1.296e-08
121 EPITHELIAL CELL DIFFERENTIATION 68 495 3.433e-10 1.32e-08
122 CELL PROLIFERATION 84 672 3.55e-10 1.354e-08
123 CELL FATE COMMITMENT 41 227 4.041e-10 1.516e-08
124 LYMPHOCYTE DIFFERENTIATION 39 209 4.014e-10 1.516e-08
125 NEGATIVE REGULATION OF CELL DEATH 101 872 4.273e-10 1.591e-08
126 ARTERY MORPHOGENESIS 18 51 5.454e-10 2.014e-08
127 GLAND MORPHOGENESIS 25 97 5.594e-10 2.05e-08
128 REGULATION OF DEFENSE RESPONSE 91 759 5.692e-10 2.069e-08
129 POSITIVE REGULATION OF OSSIFICATION 23 84 7.442e-10 2.684e-08
130 POSITIVE REGULATION OF LOCOMOTION 60 420 8.289e-10 2.967e-08
131 REGULATION OF LEUKOCYTE PROLIFERATION 38 206 9.458e-10 3.36e-08
132 RESPONSE TO STEROID HORMONE 67 497 1.033e-09 3.643e-08
133 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 100 876 1.155e-09 4.039e-08
134 LEUKOCYTE DIFFERENTIATION 47 292 1.189e-09 4.084e-08
135 MITOTIC CELL CYCLE CHECKPOINT 30 139 1.181e-09 4.084e-08
136 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 55 372 1.194e-09 4.084e-08
137 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 84 689 1.206e-09 4.095e-08
138 RESPONSE TO NUTRIENT 36 191 1.419e-09 4.783e-08
139 CELL CYCLE CHECKPOINT 36 194 2.203e-09 7.374e-08
140 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 103 926 2.652e-09 8.798e-08
141 NEUROGENESIS 141 1402 2.666e-09 8.798e-08
142 NEGATIVE REGULATION OF CELL CYCLE 60 433 2.726e-09 8.931e-08
143 NEGATIVE REGULATION OF CELL CYCLE PROCESS 38 214 2.884e-09 9.318e-08
144 RESPONSE TO INTERFERON GAMMA 30 144 2.872e-09 9.318e-08
145 REGULATION OF OSTEOBLAST DIFFERENTIATION 26 112 2.913e-09 9.347e-08
146 REGENERATION 32 161 2.954e-09 9.415e-08
147 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 31 154 3.774e-09 1.186e-07
148 RESPONSE TO VITAMIN 24 98 3.758e-09 1.186e-07
149 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 137 1360 4.148e-09 1.295e-07
150 INTERFERON GAMMA MEDIATED SIGNALING PATHWAY 20 70 4.214e-09 1.307e-07
151 CELL DIVISION 62 460 4.409e-09 1.358e-07
152 NEGATIVE REGULATION OF MITOTIC CELL CYCLE 36 199 4.482e-09 1.372e-07
153 POSITIVE REGULATION OF CELL ADHESION 54 376 4.819e-09 1.456e-07
154 REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 30 147 4.789e-09 1.456e-07
155 INNER EAR MORPHOGENESIS 23 92 5.158e-09 1.548e-07
156 REGULATION OF CELL ACTIVATION 64 484 5.312e-09 1.584e-07
157 ENDOCRINE SYSTEM DEVELOPMENT 27 123 5.358e-09 1.588e-07
158 REGULATION OF DNA BINDING 23 93 6.458e-09 1.902e-07
159 LEUKOCYTE MIGRATION 42 259 7.202e-09 2.108e-07
160 REGULATION OF RESPONSE TO WOUNDING 57 413 7.883e-09 2.293e-07
161 REGULATION OF RESPONSE TO STRESS 144 1468 9.114e-09 2.634e-07
162 REGULATION OF CELL CYCLE 103 949 9.774e-09 2.807e-07
163 CHROMOSOME SEGREGATION 43 272 1.043e-08 2.979e-07
164 CELL MATRIX ADHESION 26 119 1.136e-08 3.224e-07
165 RESPIRATORY SYSTEM DEVELOPMENT 35 197 1.189e-08 3.353e-07
166 POSITIVE REGULATION OF RESPONSE TO WOUNDING 31 162 1.337e-08 3.747e-07
167 ARTERY DEVELOPMENT 20 75 1.557e-08 4.313e-07
168 EYE DEVELOPMENT 48 326 1.548e-08 4.313e-07
169 NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION 29 146 1.635e-08 4.503e-07
170 NEURON DIFFERENTIATION 96 874 1.776e-08 4.86e-07
171 REGULATION OF CELL CELL ADHESION 53 380 1.844e-08 5.018e-07
172 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 109 1036 1.915e-08 5.121e-07
173 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 109 1036 1.915e-08 5.121e-07
174 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 73 602 1.893e-08 5.121e-07
175 REGULATION OF PHOSPHORUS METABOLIC PROCESS 154 1618 1.987e-08 5.283e-07
176 NEPHRON DEVELOPMENT 25 115 2.409e-08 6.37e-07
177 OSSIFICATION 40 251 2.694e-08 7.081e-07
178 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 156 1656 3.142e-08 8.213e-07
179 REGULATION OF MAPK CASCADE 77 660 4.062e-08 1.05e-06
180 MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS 20 79 4.061e-08 1.05e-06
181 REGULATION OF HOMOTYPIC CELL CELL ADHESION 45 307 4.972e-08 1.278e-06
182 CELLULAR RESPONSE TO MECHANICAL STIMULUS 20 80 5.105e-08 1.305e-06
183 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 15 46 5.133e-08 1.305e-06
184 REGULATION OF STEM CELL PROLIFERATION 21 88 5.71e-08 1.444e-06
185 POSITIVE REGULATION OF MAPK CASCADE 60 470 5.798e-08 1.457e-06
186 MITOTIC NUCLEAR DIVISION 50 361 5.824e-08 1.457e-06
187 CENTRAL NERVOUS SYSTEM DEVELOPMENT 94 872 6.179e-08 1.538e-06
188 REGULATION OF CELL DEVELOPMENT 91 836 6.469e-08 1.601e-06
189 IN UTERO EMBRYONIC DEVELOPMENT 45 311 7.338e-08 1.806e-06
190 REGULATION OF T CELL PROLIFERATION 28 147 7.377e-08 1.807e-06
191 POSITIVE REGULATION OF CELL CYCLE 47 332 7.438e-08 1.812e-06
192 PROTEIN O LINKED FUCOSYLATION 8 12 7.832e-08 1.898e-06
193 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 25 122 8.296e-08 2e-06
194 RESPONSE TO X RAY 12 30 8.366e-08 2.006e-06
195 RESPONSE TO DRUG 56 431 8.821e-08 2.105e-06
196 MULTI MULTICELLULAR ORGANISM PROCESS 35 213 9.093e-08 2.159e-06
197 POSITIVE REGULATION OF STEM CELL PROLIFERATION 17 61 9.142e-08 2.159e-06
198 MUSCLE STRUCTURE DEVELOPMENT 56 432 9.545e-08 2.243e-06
199 SISTER CHROMATID SEGREGATION 31 176 9.838e-08 2.277e-06
200 RESPONSE TO HORMONE 95 893 9.806e-08 2.277e-06
201 REGULATION OF VASCULATURE DEVELOPMENT 37 233 9.748e-08 2.277e-06
202 REGULATION OF INFLAMMATORY RESPONSE 43 294 1.046e-07 2.41e-06
203 CRANIAL SKELETAL SYSTEM DEVELOPMENT 16 55 1.128e-07 2.585e-06
204 CELLULAR RESPONSE TO LIPID 58 457 1.181e-07 2.693e-06
205 RESPONSE TO ESTROGEN 35 218 1.633e-07 3.707e-06
206 NUCLEAR CHROMOSOME SEGREGATION 36 228 1.674e-07 3.781e-06
207 MESENCHYME DEVELOPMENT 32 190 1.796e-07 4.017e-06
208 STEM CELL DIFFERENTIATION 32 190 1.796e-07 4.017e-06
209 FORMATION OF PRIMARY GERM LAYER 23 110 1.844e-07 4.104e-06
210 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 36 229 1.871e-07 4.146e-06
211 POSITIVE REGULATION OF DEFENSE RESPONSE 49 364 1.915e-07 4.223e-06
212 RESPONSE TO OXYGEN LEVELS 44 311 1.962e-07 4.307e-06
213 RESPONSE TO REACTIVE OXYGEN SPECIES 32 191 2.033e-07 4.44e-06
214 REGULATION OF PROTEIN MODIFICATION PROCESS 156 1710 2.443e-07 5.311e-06
215 POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 16 58 2.544e-07 5.481e-06
216 REPRODUCTION 125 1297 2.534e-07 5.481e-06
217 REGULATION OF STEM CELL DIFFERENTIATION 23 113 3.077e-07 6.599e-06
218 CELLULAR RESPONSE TO INTERFERON GAMMA 24 122 3.335e-07 7.117e-06
219 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 42 296 3.414e-07 7.253e-06
220 HEAD DEVELOPMENT 78 709 3.787e-07 8.009e-06
221 NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 21 98 4.044e-07 8.514e-06
222 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 16 60 4.237e-07 8.881e-06
223 ADAPTIVE IMMUNE RESPONSE 41 288 4.296e-07 8.948e-06
224 RESPONSE TO OXIDATIVE STRESS 47 352 4.308e-07 8.948e-06
225 RESPONSE TO EXTRACELLULAR STIMULUS 55 441 4.418e-07 9.137e-06
226 TAXIS 57 464 4.517e-07 9.3e-06
227 CELLULAR RESPONSE TO CYTOKINE STIMULUS 69 606 5.164e-07 1.058e-05
228 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 25 134 5.48e-07 1.118e-05
229 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 61 513 5.542e-07 1.126e-05
230 EXTRACELLULAR MATRIX DISASSEMBLY 18 76 5.649e-07 1.143e-05
231 MITOTIC DNA INTEGRITY CHECKPOINT 21 100 5.775e-07 1.158e-05
232 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 21 100 5.775e-07 1.158e-05
233 MAMMARY GLAND DEVELOPMENT 23 117 5.907e-07 1.18e-05
234 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 111 1135 6.15e-07 1.223e-05
235 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 26 144 6.343e-07 1.256e-05
236 RESPONSE TO HYDROGEN PEROXIDE 22 109 6.441e-07 1.27e-05
237 FUCOSYLATION 10 24 6.514e-07 1.279e-05
238 REGULATION OF HEMOPOIESIS 43 314 6.657e-07 1.301e-05
239 MULTICELLULAR ORGANISM METABOLIC PROCESS 20 93 7.15e-07 1.392e-05
240 CARDIAC SEPTUM DEVELOPMENT 19 85 7.198e-07 1.396e-05
241 RESPONSE TO IONIZING RADIATION 26 145 7.284e-07 1.406e-05
242 REGULATION OF ORGAN MORPHOGENESIS 36 242 7.416e-07 1.426e-05
243 HEART MORPHOGENESIS 33 212 7.54e-07 1.444e-05
244 AUTONOMIC NERVOUS SYSTEM DEVELOPMENT 13 42 7.911e-07 1.509e-05
245 POSITIVE REGULATION OF CELL CELL ADHESION 36 243 8.202e-07 1.558e-05
246 ORGANELLE FISSION 59 496 8.386e-07 1.585e-05
247 NEGATIVE REGULATION OF CELL ADHESION 34 223 8.415e-07 1.585e-05
248 DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION 8 15 8.618e-07 1.617e-05
249 REGULATION OF CARTILAGE DEVELOPMENT 16 63 8.713e-07 1.628e-05
250 SISTER CHROMATID COHESION 22 111 8.924e-07 1.661e-05
251 OUTFLOW TRACT MORPHOGENESIS 15 56 9.117e-07 1.69e-05
252 SEX DIFFERENTIATION 38 266 1.031e-06 1.904e-05
253 RESPONSE TO CORTICOSTEROID 29 176 1.064e-06 1.957e-05
254 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 56 465 1.076e-06 1.971e-05
255 INNATE IMMUNE RESPONSE 69 619 1.12e-06 2.043e-05
256 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 21 104 1.142e-06 2.076e-05
257 POSITIVE REGULATION OF INFLAMMATORY RESPONSE 22 113 1.226e-06 2.211e-05
258 CELLULAR RESPONSE TO STRESS 142 1565 1.226e-06 2.211e-05
259 RESPONSE TO INORGANIC SUBSTANCE 57 479 1.268e-06 2.279e-05
260 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 32 207 1.289e-06 2.306e-05
261 G1 DNA DAMAGE CHECKPOINT 17 73 1.493e-06 2.662e-05
262 CELLULAR RESPONSE TO ALCOHOL 22 115 1.669e-06 2.965e-05
263 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 24 133 1.712e-06 3.028e-05
264 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 79 750 1.78e-06 3.137e-05
265 REGULATION OF CELL DIVISION 38 272 1.795e-06 3.151e-05
266 INTEGRIN MEDIATED SIGNALING PATHWAY 18 82 1.857e-06 3.249e-05
267 SKIN DEVELOPMENT 32 211 1.971e-06 3.436e-05
268 REGULATION OF CELL CYCLE PROCESS 63 558 2.143e-06 3.72e-05
269 ORGAN REGENERATION 18 83 2.237e-06 3.855e-05
270 CELLULAR RESPONSE TO BIOTIC STIMULUS 27 163 2.232e-06 3.855e-05
271 ANTIGEN PROCESSING AND PRESENTATION 32 213 2.426e-06 4.165e-05
272 RESPONSE TO VITAMIN D 11 33 2.466e-06 4.218e-05
273 NEGATIVE REGULATION OF DNA BINDING 13 46 2.506e-06 4.271e-05
274 MAMMARY GLAND EPITHELIUM DEVELOPMENT 14 53 2.519e-06 4.277e-05
275 POSITIVE REGULATION OF LEUKOCYTE MIGRATION 21 109 2.538e-06 4.294e-05
276 SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 23 127 2.624e-06 4.423e-05
277 DNA METABOLIC PROCESS 79 758 2.67e-06 4.486e-05
278 MUSCLE ORGAN DEVELOPMENT 38 277 2.802e-06 4.689e-05
279 RESPONSE TO ESTRADIOL 25 146 2.834e-06 4.71e-05
280 DNA INTEGRITY CHECKPOINT 25 146 2.834e-06 4.71e-05
281 REGULATION OF CELL CYCLE PHASE TRANSITION 42 321 2.964e-06 4.908e-05
282 REGULATION OF MULTI ORGANISM PROCESS 55 470 3.241e-06 5.348e-05
283 POSITIVE REGULATION OF CELL CYCLE PROCESS 35 247 3.279e-06 5.372e-05
284 RESPONSE TO VIRUS 35 247 3.279e-06 5.372e-05
285 TUBE FORMATION 23 129 3.459e-06 5.648e-05
286 CYTOKINE PRODUCTION 22 120 3.49e-06 5.678e-05
287 REGULATION OF SMOOTHENED SIGNALING PATHWAY 15 62 3.686e-06 5.975e-05
288 NEGATIVE REGULATION OF CELL ACTIVATION 26 158 3.874e-06 6.259e-05
289 INTRACELLULAR SIGNAL TRANSDUCTION 140 1572 4.008e-06 6.454e-05
290 DNA REPLICATION 31 208 4.107e-06 6.59e-05
291 REGULATION OF LEUKOCYTE MIGRATION 25 149 4.136e-06 6.613e-05
292 POSITIVE REGULATION OF T CELL PROLIFERATION 19 95 4.241e-06 6.758e-05
293 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS 9 23 4.487e-06 7.126e-05
294 ENDODERM DEVELOPMENT 16 71 4.781e-06 7.541e-05
295 CELL FATE SPECIFICATION 16 71 4.781e-06 7.541e-05
296 MUSCLE CELL MIGRATION 8 18 4.962e-06 7.774e-05
297 UTERUS DEVELOPMENT 8 18 4.962e-06 7.774e-05
298 REGULATION OF CHEMOTAXIS 28 180 5.148e-06 8.033e-05
299 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 29 190 5.162e-06 8.033e-05
300 CARDIAC SEPTUM MORPHOGENESIS 13 49 5.442e-06 8.441e-05
301 POSITIVE REGULATION OF IMMUNE RESPONSE 62 563 5.778e-06 8.932e-05
302 CELLULAR RESPONSE TO EXTERNAL STIMULUS 36 264 5.826e-06 8.976e-05
303 MUSCLE TISSUE DEVELOPMENT 37 275 5.948e-06 9.134e-05
304 NEGATIVE REGULATION OF CELL COMMUNICATION 111 1192 6.18e-06 9.459e-05
305 MESENCHYMAL CELL DIFFERENTIATION 23 134 6.712e-06 0.0001024
306 CELL CYCLE PHASE TRANSITION 35 255 6.755e-06 0.0001027
307 MORPHOGENESIS OF AN EPITHELIAL SHEET 12 43 7.043e-06 0.0001067
308 POSITIVE REGULATION OF CELL DEVELOPMENT 54 472 7.721e-06 0.0001166
309 CELLULAR RESPONSE TO OXIDATIVE STRESS 28 184 7.908e-06 0.0001191
310 REGULATION OF SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM 30 205 8.462e-06 0.000127
311 GASTRULATION 25 155 8.498e-06 0.0001271
312 CORONARY VASCULATURE DEVELOPMENT 11 37 8.676e-06 0.000129
313 POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION 23 136 8.655e-06 0.000129
314 IMMUNE EFFECTOR PROCESS 55 486 8.778e-06 0.0001301
315 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 31 216 9.019e-06 0.0001332
316 EPITHELIAL CELL DEVELOPMENT 28 186 9.745e-06 0.0001435
317 REGULATION OF ERK1 AND ERK2 CASCADE 33 238 9.877e-06 0.000145
318 HEPATICOBILIARY SYSTEM DEVELOPMENT 22 128 1.033e-05 0.0001512
319 INTERSPECIES INTERACTION BETWEEN ORGANISMS 69 662 1.143e-05 0.0001663
320 SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM 69 662 1.143e-05 0.0001663
321 COLLAGEN FIBRIL ORGANIZATION 11 38 1.154e-05 0.0001672
322 THYMOCYTE AGGREGATION 12 45 1.178e-05 0.0001692
323 REGULATION OF EPIDERMAL CELL DIFFERENTIATION 12 45 1.178e-05 0.0001692
324 T CELL DIFFERENTIATION IN THYMUS 12 45 1.178e-05 0.0001692
325 POSITIVE REGULATION OF CHEMOTAXIS 21 120 1.225e-05 0.0001754
326 CELL CYCLE G1 S PHASE TRANSITION 20 111 1.253e-05 0.0001778
327 G1 S TRANSITION OF MITOTIC CELL CYCLE 20 111 1.253e-05 0.0001778
328 REGULATION OF MITOTIC CELL CYCLE 53 468 1.248e-05 0.0001778
329 NEGATIVE REGULATION OF LOCOMOTION 35 263 1.338e-05 0.0001892
330 PROXIMAL DISTAL PATTERN FORMATION 10 32 1.364e-05 0.0001923
331 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 13 53 1.386e-05 0.0001948
332 RESPONSE TO ACID CHEMICAL 40 319 1.412e-05 0.0001979
333 EMBRYONIC DIGIT MORPHOGENESIS 14 61 1.487e-05 0.0002078
334 REGULATION OF CHONDROCYTE DIFFERENTIATION 12 46 1.505e-05 0.0002097
335 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 18 95 1.651e-05 0.0002293
336 RENAL TUBULE DEVELOPMENT 16 78 1.711e-05 0.0002369
337 RESPONSE TO METAL ION 41 333 1.718e-05 0.0002372
338 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 55 498 1.773e-05 0.0002441
339 POSITIVE REGULATION OF CELL ACTIVATION 39 311 1.796e-05 0.0002465
340 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 30 213 1.814e-05 0.0002482
341 POSITIVE REGULATION OF ENDOCYTOSIS 20 114 1.886e-05 0.0002566
342 NOTCH SIGNALING PATHWAY 20 114 1.886e-05 0.0002566
343 SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE 18 96 1.917e-05 0.0002601
344 COCHLEA MORPHOGENESIS 8 21 1.955e-05 0.0002644
345 MAMMARY GLAND MORPHOGENESIS 11 40 1.979e-05 0.0002661
346 ENDODERMAL CELL DIFFERENTIATION 11 40 1.979e-05 0.0002661
347 CYTOKINE MEDIATED SIGNALING PATHWAY 51 452 2e-05 0.0002682
348 REGULATION OF CELL SUBSTRATE ADHESION 26 173 2.06e-05 0.0002746
349 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 9 27 2.058e-05 0.0002746
350 POSITIVE REGULATION OF HEMOPOIESIS 25 163 2.074e-05 0.0002757
351 NEURON DEVELOPMENT 70 687 2.096e-05 0.0002779
352 REGULATION OF KIDNEY DEVELOPMENT 13 55 2.131e-05 0.0002817
353 REGULATION OF EPIDERMIS DEVELOPMENT 14 63 2.201e-05 0.0002892
354 NEGATIVE REGULATION OF MOLECULAR FUNCTION 100 1079 2.2e-05 0.0002892
355 REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION 7 16 2.263e-05 0.0002966
356 HOMEOSTATIC PROCESS 119 1337 2.303e-05 0.000301
357 KIDNEY EPITHELIUM DEVELOPMENT 21 125 2.33e-05 0.0003036
358 DIGESTIVE TRACT MORPHOGENESIS 12 48 2.404e-05 0.0003125
359 REGULATION OF MESENCHYMAL CELL PROLIFERATION 10 34 2.476e-05 0.0003209
360 HOMEOSTASIS OF NUMBER OF CELLS 26 175 2.527e-05 0.0003266
361 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 11 41 2.555e-05 0.0003284
362 AORTA DEVELOPMENT 11 41 2.555e-05 0.0003284
363 RESPONSE TO NITROGEN COMPOUND 83 859 2.612e-05 0.0003348
364 DEFENSE RESPONSE TO OTHER ORGANISM 55 505 2.628e-05 0.000336
365 OSTEOBLAST DIFFERENTIATION 21 126 2.636e-05 0.0003361
366 EYE MORPHOGENESIS 22 136 2.762e-05 0.0003511
367 METANEPHROS DEVELOPMENT 16 81 2.808e-05 0.000356
368 REGULATION OF EPITHELIAL CELL MIGRATION 25 166 2.844e-05 0.0003596
369 BONE DEVELOPMENT 24 156 2.86e-05 0.0003606
370 AORTA MORPHOGENESIS 8 22 2.906e-05 0.0003645
371 POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT 8 22 2.906e-05 0.0003645
372 PANCREAS DEVELOPMENT 15 73 3.048e-05 0.0003813
373 ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN 26 177 3.089e-05 0.0003853
374 REGULATION OF IMMUNE EFFECTOR PROCESS 48 424 3.192e-05 0.0003971
375 KIDNEY MORPHOGENESIS 16 82 3.292e-05 0.0004085
376 MYELOID CELL DIFFERENTIATION 27 189 3.626e-05 0.0004487
377 ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN 7 17 3.644e-05 0.0004497
378 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 12 50 3.738e-05 0.0004589
379 ENDODERM FORMATION 12 50 3.738e-05 0.0004589
380 REGULATION OF LEUKOCYTE DIFFERENTIATION 31 232 3.768e-05 0.0004614
381 REGULATION OF INTERLEUKIN 1 PRODUCTION 13 58 3.902e-05 0.0004766
382 REGULATION OF INNATE IMMUNE RESPONSE 42 357 4.037e-05 0.0004917
383 CRANIAL NERVE DEVELOPMENT 11 43 4.153e-05 0.0005046
384 CRANIAL NERVE MORPHOGENESIS 8 23 4.217e-05 0.0005097
385 REGULATION OF ANTIGEN PROCESSING AND PRESENTATION 8 23 4.217e-05 0.0005097
386 REGULATION OF VIRAL GENOME REPLICATION 15 75 4.258e-05 0.0005133
387 REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 10 36 4.289e-05 0.0005144
388 T CELL SELECTION 10 36 4.289e-05 0.0005144
389 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 19 111 4.307e-05 0.0005151
390 REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS 14 67 4.576e-05 0.0005459
391 REGULATION OF NEURON APOPTOTIC PROCESS 27 192 4.798e-05 0.000571
392 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 18 103 5.119e-05 0.0006076
393 POSITIVE REGULATION OF CELL CYCLE ARREST 16 85 5.217e-05 0.0006161
394 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 25 172 5.204e-05 0.0006161
395 NEURAL TUBE FORMATION 17 94 5.24e-05 0.0006173
396 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 9 30 5.313e-05 0.0006243
397 REGULATION OF MYELOID CELL DIFFERENTIATION 26 183 5.513e-05 0.0006462
398 PHARYNGEAL SYSTEM DEVELOPMENT 7 18 5.646e-05 0.0006601
399 NEGATIVE REGULATION OF CELL DIVISION 13 60 5.699e-05 0.0006629
400 MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY 13 60 5.699e-05 0.0006629
401 CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 18 104 5.84e-05 0.0006777
402 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 68 684 5.905e-05 0.0006835
403 REGULATION OF ODONTOGENESIS 8 24 5.986e-05 0.0006912
404 EYELID DEVELOPMENT IN CAMERA TYPE EYE 6 13 6.245e-05 0.0007157
405 PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION 6 13 6.245e-05 0.0007157
406 PERIPHERAL NERVOUS SYSTEM NEURON DEVELOPMENT 6 13 6.245e-05 0.0007157
407 NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION 14 69 6.444e-05 0.0007367
408 LUNG MORPHOGENESIS 11 45 6.545e-05 0.0007445
409 SPROUTING ANGIOGENESIS 11 45 6.545e-05 0.0007445
410 REGULATION OF TRANSPORT 150 1804 6.567e-05 0.0007453
411 ODONTOGENESIS 18 105 6.65e-05 0.0007529
412 INTERACTION WITH HOST 21 134 6.719e-05 0.0007588
413 CARDIAC CHAMBER DEVELOPMENT 22 144 6.749e-05 0.0007604
414 POSITIVE REGULATION OF TRANSPORT 87 936 6.833e-05 0.000768
415 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 12 53 6.925e-05 0.0007764
416 CELLULAR RESPONSE TO ACID CHEMICAL 25 175 6.945e-05 0.0007768
417 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 19 115 7.098e-05 0.000792
418 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 10 38 7.129e-05 0.0007935
419 SPINAL CORD DEVELOPMENT 18 106 7.558e-05 0.0008393
420 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 24 166 7.94e-05 0.0008796
421 FEMALE SEX DIFFERENTIATION 19 116 8.008e-05 0.000885
422 POSITIVE REGULATION OF COAGULATION 8 25 8.332e-05 0.0009165
423 CELLULAR EXTRAVASATION 8 25 8.332e-05 0.0009165
424 FOREBRAIN DEVELOPMENT 41 357 8.536e-05 0.0009367
425 REGULATION OF ENDOCYTOSIS 27 199 8.96e-05 0.0009809
426 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 17 98 9.021e-05 0.0009853
427 COCHLEA DEVELOPMENT 10 39 9.063e-05 0.0009876
428 REGULATION OF CELL CYCLE ARREST 18 108 9.707e-05 0.001055
429 REGULATION OF BODY FLUID LEVELS 53 506 0.0001023 0.00111
430 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE 6 14 0.0001036 0.001115
431 REGULATION OF FIBROBLAST APOPTOTIC PROCESS 6 14 0.0001036 0.001115
432 PLACENTA DEVELOPMENT 21 138 0.0001037 0.001115
433 ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN 6 14 0.0001036 0.001115
434 MESONEPHROS DEVELOPMENT 16 90 0.0001066 0.001143
435 POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION 15 81 0.0001076 0.001148
436 POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 15 81 0.0001076 0.001148
437 NEURAL TUBE DEVELOPMENT 22 149 0.0001133 0.001203
438 FORELIMB MORPHOGENESIS 10 40 0.0001142 0.001203
439 REGULATION OF MESONEPHROS DEVELOPMENT 8 26 0.0001139 0.001203
440 ENDOCRINE PANCREAS DEVELOPMENT 10 40 0.0001142 0.001203
441 REGULATION OF CYTOKINE SECRETION 22 149 0.0001133 0.001203
442 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 8 26 0.0001139 0.001203
443 MITOTIC SISTER CHROMATID SEGREGATION 16 91 0.0001221 0.001281
444 EPITHELIAL TO MESENCHYMAL TRANSITION 12 56 0.0001222 0.001281
445 MIDDLE EAR MORPHOGENESIS 7 20 0.0001234 0.001284
446 POSITIVE REGULATION OF WOUND HEALING 11 48 0.000123 0.001284
447 REGULATION OF APOPTOTIC SIGNALING PATHWAY 41 363 0.0001232 0.001284
448 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 24 171 0.0001273 0.001322
449 CELLULAR COMPONENT MORPHOGENESIS 83 900 0.0001301 0.001348
450 RESPONSE TO KETONE 25 182 0.0001319 0.001364
451 REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 17 101 0.0001326 0.001368
452 MUSCLE CELL DIFFERENTIATION 30 237 0.0001353 0.001392
453 POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION 13 65 0.0001361 0.001398
454 POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS 18 111 0.0001394 0.001428
455 CELL CHEMOTAXIS 23 162 0.0001465 0.001494
456 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 23 162 0.0001465 0.001494
457 GLOMERULUS DEVELOPMENT 11 49 0.0001498 0.001526
458 ACTIVATION OF IMMUNE RESPONSE 46 427 0.000151 0.001534
459 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 22 152 0.0001524 0.001545
460 CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS 8 27 0.0001532 0.00155
461 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 9 34 0.0001559 0.001574
462 RESPONSE TO AMINO ACID 18 112 0.0001567 0.001578
463 NEPHRON EPITHELIUM DEVELOPMENT 16 93 0.000159 0.001598
464 TELENCEPHALON DEVELOPMENT 29 228 0.0001596 0.0016
465 RESPONSE TO MURAMYL DIPEPTIDE 6 15 0.0001637 0.001631
466 INTERLEUKIN 1 PRODUCTION 6 15 0.0001637 0.001631
467 MORPHOGENESIS OF AN EPITHELIAL FOLD 6 15 0.0001637 0.001631
468 TYROSINE PHOSPHORYLATION OF STAT PROTEIN 5 10 0.0001681 0.001672
469 REGULATION OF MUSCLE TISSUE DEVELOPMENT 17 103 0.0001697 0.001677
470 REGULATION OF NEURON DIFFERENTIATION 56 554 0.000169 0.001677
471 REGULATION OF MUSCLE ORGAN DEVELOPMENT 17 103 0.0001697 0.001677
472 CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS 12 58 0.0001742 0.001717
473 SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT 7 21 0.0001753 0.001724
474 POSITIVE REGULATION OF DNA BINDING 10 42 0.0001773 0.001737
475 METAPHASE PLATE CONGRESSION 10 42 0.0001773 0.001737
476 RESPONSE TO TOXIC SUBSTANCE 30 241 0.0001824 0.001783
477 AGING 32 264 0.0001857 0.001811
478 CARDIAC CHAMBER MORPHOGENESIS 17 104 0.0001915 0.001864
479 REGULATION OF NEUROBLAST PROLIFERATION 8 28 0.000203 0.001964
480 MORPHOGENESIS OF A POLARIZED EPITHELIUM 8 28 0.000203 0.001964
481 MAMMARY GLAND DUCT MORPHOGENESIS 8 28 0.000203 0.001964
482 REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 12 59 0.0002066 0.001995
483 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 15 86 0.0002159 0.00208
484 CELL FATE DETERMINATION 10 43 0.0002184 0.0021
485 NERVE DEVELOPMENT 13 68 0.0002191 0.002102
486 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 22 156 0.0002229 0.002134
487 REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 29 233 0.0002323 0.002208
488 POSITIVE REGULATION OF CYTOKINE SECRETION 16 96 0.0002326 0.002208
489 CARDIOCYTE DIFFERENTIATION 16 96 0.0002326 0.002208
490 REGULATION OF LEUKOCYTE CHEMOTAXIS 16 96 0.0002326 0.002208
491 NEGATIVE REGULATION OF CYTOKINE PRODUCTION 27 211 0.0002396 0.00227
492 NEGATIVE REGULATION OF ORGANELLE ORGANIZATION 42 387 0.0002453 0.00232
493 CARDIAC RIGHT VENTRICLE MORPHOGENESIS 6 16 0.0002484 0.002335
494 NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT 6 16 0.0002484 0.002335
495 CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 6 16 0.0002484 0.002335
496 POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 24 179 0.0002582 0.002422
497 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 8 29 0.0002653 0.002479
498 RESPONSE TO RADIATION 44 413 0.0002659 0.002479
499 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 8 29 0.0002653 0.002479
500 LEUKOCYTE CHEMOTAXIS 18 117 0.0002746 0.002556
501 CELLULAR RESPONSE TO HYDROGEN PEROXIDE 12 61 0.000287 0.002666
502 POSITIVE REGULATION OF MEMBRANE INVAGINATION 5 11 0.0002927 0.002697
503 NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 5 11 0.0002927 0.002697
504 INTESTINAL EPITHELIAL CELL DEVELOPMENT 5 11 0.0002927 0.002697
505 POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT 5 11 0.0002927 0.002697
506 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 95 1087 0.0002972 0.002727
507 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 16 98 0.0002966 0.002727
508 NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 9 37 0.0003131 0.002867
509 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 16 99 0.0003339 0.003047
510 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 16 99 0.0003339 0.003047
511 EMBRYONIC HEART TUBE MORPHOGENESIS 12 62 0.0003363 0.003062
512 PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 17 109 0.0003406 0.003096
513 SKIN EPIDERMIS DEVELOPMENT 13 71 0.000342 0.003102
514 ESTABLISHMENT OF TISSUE POLARITY 6 17 0.000364 0.003263
515 INTESTINAL EPITHELIAL CELL DIFFERENTIATION 6 17 0.000364 0.003263
516 MAMMARY GLAND ALVEOLUS DEVELOPMENT 6 17 0.000364 0.003263
517 MAMMARY GLAND LOBULE DEVELOPMENT 6 17 0.000364 0.003263
518 REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 6 17 0.000364 0.003263
519 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 32 274 0.0003638 0.003263
520 RHYTHMIC PROCESS 34 298 0.0003741 0.003347
521 REGULATION OF FIBROBLAST PROLIFERATION 14 81 0.000382 0.00341
522 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 22 162 0.0003825 0.00341
523 REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 9 38 0.0003881 0.003453
524 REGULATION OF NEURON DEATH 30 252 0.0003959 0.003516
525 REGULATION OF MUSCLE CELL DIFFERENTIATION 21 152 0.0004068 0.003606
526 PROTEIN LOCALIZATION 145 1805 0.0004154 0.003675
527 REGULATION OF NUCLEAR DIVISION 22 163 0.0004171 0.003681
528 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 18 121 0.0004185 0.003681
529 NEGATIVE REGULATION OF IMMUNE RESPONSE 18 121 0.0004185 0.003681
530 PROTEIN O LINKED GLYCOSYLATION 16 101 0.000421 0.003696
531 EPIDERMIS DEVELOPMENT 30 253 0.0004234 0.00371
532 SECRETION 57 588 0.0004325 0.003782
533 POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION 8 31 0.000437 0.003815
534 NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 11 55 0.0004388 0.003816
535 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 11 55 0.0004388 0.003816
536 NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION 7 24 0.0004435 0.00385
537 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 21 153 0.0004448 0.003854
538 MAINTENANCE OF CELL NUMBER 19 132 0.0004486 0.00388
539 EMBRYONIC HEART TUBE DEVELOPMENT 13 73 0.0004531 0.003897
540 CELLULAR RESPONSE TO KETONE 13 73 0.0004531 0.003897
541 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 13 73 0.0004531 0.003897
542 THYMUS DEVELOPMENT 10 47 0.0004716 0.004041
543 NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION 16 102 0.0004713 0.004041
544 POSITIVE REGULATION OF CELLULAR EXTRAVASATION 5 12 0.0004764 0.004067
545 CELL ADHESION MEDIATED BY INTEGRIN 5 12 0.0004764 0.004067
546 ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS 21 154 0.0004859 0.004141
547 EMBRYONIC PLACENTA DEVELOPMENT 14 83 0.0004942 0.004204
548 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 11 56 0.0005161 0.004382
549 REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS 6 18 0.0005177 0.004388
550 REGULATION OF ACUTE INFLAMMATORY RESPONSE 13 74 0.0005193 0.004393
551 OVULATION CYCLE 17 113 0.000524 0.004425
552 CHROMOSOME ORGANIZATION 88 1009 0.0005269 0.004442
553 REGULATION OF GROWTH 60 633 0.0005491 0.00462
554 POSITIVE REGULATION OF BMP SIGNALING PATHWAY 8 32 0.0005516 0.004625
555 EMBRYONIC FORELIMB MORPHOGENESIS 8 32 0.0005516 0.004625
556 REGULATION OF INTERLEUKIN 1 BETA PRODUCTION 10 48 0.0005634 0.004681
557 COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT 10 48 0.0005634 0.004681
558 MICROTUBULE ORGANIZING CENTER ORGANIZATION 14 84 0.0005602 0.004681
559 REGULATION OF INTERLEUKIN 2 PRODUCTION 10 48 0.0005634 0.004681
560 POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 10 48 0.0005634 0.004681
561 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 25 200 0.0005697 0.004725
562 EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS 7 25 0.0005836 0.004781
563 NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY 7 25 0.0005836 0.004781
564 RESPONSE TO BMP 15 94 0.0005819 0.004781
565 PROTEIN LOCALIZATION TO ORGANELLE 54 556 0.0005788 0.004781
566 NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 9 40 0.0005827 0.004781
567 CELLULAR RESPONSE TO BMP STIMULUS 15 94 0.0005819 0.004781
568 THYROID GLAND DEVELOPMENT 7 25 0.0005836 0.004781
569 RESPONSE TO CAMP 16 104 0.0005878 0.004798
570 REGULATION OF INTERLEUKIN 6 PRODUCTION 16 104 0.0005878 0.004798
571 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 13 75 0.0005934 0.004827
572 ODONTOGENESIS OF DENTIN CONTAINING TOOTH 13 75 0.0005934 0.004827
573 POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 11 57 0.0006046 0.00491
574 MESODERM MORPHOGENESIS 12 66 0.0006112 0.004954
575 NEURON PROJECTION DEVELOPMENT 53 545 0.0006289 0.005089
576 REGULATION OF BINDING 32 283 0.0006399 0.005169
577 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 26 213 0.0006428 0.005184
578 CARDIAC CELL DEVELOPMENT 10 49 0.0006694 0.005389
579 RESPONSE TO PURINE CONTAINING COMPOUND 21 158 0.000685 0.005505
580 RESPONSE TO DEXAMETHASONE 8 33 0.0006894 0.005511
581 EMBRYONIC EYE MORPHOGENESIS 8 33 0.0006894 0.005511
582 REGULATION OF INTERLEUKIN 1 SECRETION 8 33 0.0006894 0.005511
583 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 9 41 0.0007064 0.005629
584 PROSTATE GLAND DEVELOPMENT 9 41 0.0007064 0.005629
585 RESPONSE TO FIBROBLAST GROWTH FACTOR 17 116 0.0007122 0.005665
586 RESPONSE TO MUSCLE STRETCH 6 19 0.0007176 0.005688
587 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 6 19 0.0007176 0.005688
588 VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION 5 13 0.0007351 0.005758
589 REGULATION OF PHAGOCYTOSIS ENGULFMENT 5 13 0.0007351 0.005758
590 LEUKOCYTE TETHERING OR ROLLING 5 13 0.0007351 0.005758
591 LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL 5 13 0.0007351 0.005758
592 NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION 5 13 0.0007351 0.005758
593 POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION 5 13 0.0007351 0.005758
594 REGULATION OF MEMBRANE INVAGINATION 5 13 0.0007351 0.005758
595 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 30 262 0.0007578 0.005916
596 MESODERMAL CELL DIFFERENTIATION 7 26 0.0007567 0.005916
597 FACE DEVELOPMENT 10 50 0.0007913 0.006168
598 TISSUE REMODELING 14 87 0.0008044 0.006259
599 HEMOSTASIS 34 311 0.000806 0.006261
600 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 12 68 0.0008074 0.006261
601 REGULATION OF INTERFERON GAMMA PRODUCTION 15 97 0.0008157 0.006315
602 REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 9 42 0.0008508 0.006554
603 PITUITARY GLAND DEVELOPMENT 9 42 0.0008508 0.006554
604 REGULATION OF NIK NF KAPPAB SIGNALING 9 42 0.0008508 0.006554
605 MESODERM DEVELOPMENT 17 118 0.0008675 0.006672
606 CHEMICAL HOMEOSTASIS 77 874 0.000871 0.006681
607 SOMITE DEVELOPMENT 13 78 0.0008716 0.006681
608 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 44 437 0.0008761 0.006705
609 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 36 337 0.0008785 0.006712
610 REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 16 108 0.0008958 0.006833
611 MYELOID CELL HOMEOSTASIS 14 88 0.0009035 0.006869
612 NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 14 88 0.0009035 0.006869
613 REGULATION OF CYTOSKELETON ORGANIZATION 49 502 0.0009137 0.006936
614 CELLULAR COMPONENT DISASSEMBLY 50 515 0.0009162 0.006943
615 NEGATIVE REGULATION OF OSSIFICATION 12 69 0.0009237 0.006989
616 CARDIAC MUSCLE TISSUE DEVELOPMENT 19 140 0.0009361 0.007071
617 NEGATIVE REGULATION OF MULTI ORGANISM PROCESS 20 151 0.0009493 0.007159
618 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS 7 27 0.0009679 0.007264
619 AXIS ELONGATION 7 27 0.0009679 0.007264
620 CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS 7 27 0.0009679 0.007264
621 REGULATION OF MACROPHAGE DIFFERENTIATION 6 20 0.0009722 0.007285
622 NEGATIVE REGULATION OF VIRAL PROCESS 14 89 0.001013 0.00754
623 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 37 352 0.00101 0.00754
624 NEURON PROJECTION MORPHOGENESIS 41 402 0.001008 0.00754
625 EPITHELIAL CELL PROLIFERATION 14 89 0.001013 0.00754
626 CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS 9 43 0.001018 0.007568
627 CYTOSKELETON ORGANIZATION 74 838 0.001023 0.007594
628 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 26 220 0.001042 0.007719
629 REGULATION OF GASTRULATION 8 35 0.001048 0.007749
630 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 12 70 0.001054 0.007782
631 GLYCOPROTEIN METABOLIC PROCESS 37 353 0.001063 0.007842
632 TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY 5 14 0.001086 0.00794
633 POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 18 131 0.00109 0.00794
634 TISSUE REGENERATION 10 52 0.00109 0.00794
635 NEGATIVE REGULATION OF T CELL PROLIFERATION 10 52 0.00109 0.00794
636 NEGATIVE REGULATION OF BINDING 18 131 0.00109 0.00794
637 T CELL MIGRATION 5 14 0.001086 0.00794
638 POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 5 14 0.001086 0.00794
639 RESPONSE TO LAMINAR FLUID SHEAR STRESS 5 14 0.001086 0.00794
640 CHROMOSOME LOCALIZATION 11 61 0.001094 0.007957
641 GLIOGENESIS 22 175 0.001099 0.00798
642 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 13 80 0.001112 0.00806
643 DEFENSE RESPONSE TO VIRUS 21 164 0.001115 0.008065
644 AXIS SPECIFICATION 14 90 0.001133 0.008173
645 ENDOTHELIUM DEVELOPMENT 14 90 0.001133 0.008173
646 RESPONSE TO TUMOR NECROSIS FACTOR 27 233 0.001135 0.008175
647 REGULATION OF PEPTIDASE ACTIVITY 40 392 0.001143 0.00822
648 CELLULAR RESPONSE TO DNA DAMAGE STIMULUS 65 720 0.001174 0.008431
649 RAS PROTEIN SIGNAL TRANSDUCTION 19 143 0.001211 0.008671
650 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 9 44 0.001211 0.008671
651 NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 7 28 0.001223 0.008688
652 POSITIVE REGULATION OF INNATE IMMUNE RESPONSE 28 246 0.001223 0.008688
653 DOPAMINERGIC NEURON DIFFERENTIATION 7 28 0.001223 0.008688
654 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 46 470 0.001222 0.008688
655 T CELL MEDIATED IMMUNITY 7 28 0.001223 0.008688
656 MESONEPHRIC TUBULE MORPHOGENESIS 10 53 0.001271 0.008988
657 CELLULAR RESPONSE TO AMINO ACID STIMULUS 10 53 0.001271 0.008988
658 INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR 10 53 0.001271 0.008988
659 POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION 8 36 0.001275 0.009005
660 POSITIVE REGULATION OF NEUROBLAST PROLIFERATION 6 21 0.001291 0.009088
661 DECIDUALIZATION 6 21 0.001291 0.009088
662 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 96 1152 0.001321 0.009287
663 ENDOTHELIAL CELL DIFFERENTIATION 12 72 0.001359 0.009524
664 DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM 12 72 0.001359 0.009524
665 REGULATION OF PROTEOLYSIS 64 711 0.001372 0.009598
666 POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS 20 156 0.001424 0.009934
667 PROTEIN LOCALIZATION TO NUCLEUS 20 156 0.001424 0.009934
NumGOOverlapSizeP ValueAdj. P Value
1 SEQUENCE SPECIFIC DNA BINDING 161 1037 1.038e-28 9.641e-26
2 DOUBLE STRANDED DNA BINDING 129 764 1.843e-26 8.559e-24
3 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 76 328 1.995e-24 6.179e-22
4 REGULATORY REGION NUCLEIC ACID BINDING 128 818 3.664e-23 8.51e-21
5 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 163 1199 1.222e-22 2.27e-20
6 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 57 226 1.698e-20 2.629e-18
7 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 68 315 3.618e-20 4.801e-18
8 CORE PROMOTER PROXIMAL REGION DNA BINDING 72 371 1.555e-18 1.805e-16
9 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 98 629 8.91e-18 9.197e-16
10 MACROMOLECULAR COMPLEX BINDING 158 1399 2.396e-14 2.226e-12
11 RECEPTOR BINDING 150 1476 3.705e-10 3.129e-08
12 PROTEIN COMPLEX BINDING 105 935 1.084e-09 8.393e-08
13 IDENTICAL PROTEIN BINDING 127 1209 1.278e-09 9.135e-08
14 CHROMATIN BINDING 58 435 2.063e-08 1.369e-06
15 CORE PROMOTER BINDING 29 152 4.175e-08 2.484e-06
16 COLLAGEN BINDING 18 65 4.279e-08 2.484e-06
17 GROWTH FACTOR BINDING 25 123 9.813e-08 5.363e-06
18 RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 14 53 2.519e-06 0.00013
19 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 17 76 2.711e-06 0.0001325
20 GLYCOSAMINOGLYCAN BINDING 31 205 3.017e-06 0.0001401
21 HMG BOX DOMAIN BINDING 8 18 4.962e-06 0.0002195
22 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 20 105 5.243e-06 0.0002214
23 KINASE BINDING 65 606 8.207e-06 0.0003315
24 PROTEIN DIMERIZATION ACTIVITY 107 1149 9.138e-06 0.0003482
25 ENZYME BINDING 150 1737 9.509e-06 0.0003482
26 CELL ADHESION MOLECULE BINDING 28 186 9.745e-06 0.0003482
27 CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 19 101 1.081e-05 0.0003718
28 ENHANCER BINDING 18 93 1.216e-05 0.0003895
29 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 26 168 1.213e-05 0.0003895
30 CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS 7 15 1.344e-05 0.0004163
31 PROTEIN HOMODIMERIZATION ACTIVITY 73 722 1.817e-05 0.000542
32 INTEGRIN BINDING 19 105 1.925e-05 0.000542
33 PLATELET DERIVED GROWTH FACTOR BINDING 6 11 1.871e-05 0.000542
34 PROTEIN DOMAIN SPECIFIC BINDING 65 624 2.082e-05 0.000569
35 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 62 588 2.23e-05 0.000592
36 PROTEIN HETERODIMERIZATION ACTIVITY 52 468 2.532e-05 0.0006534
37 CYTOKINE BINDING 17 92 3.94e-05 0.0009892
38 CYTOKINE RECEPTOR BINDING 34 271 5.987e-05 0.001464
39 PEPTIDE ANTIGEN BINDING 9 31 7.081e-05 0.001656
40 CORECEPTOR ACTIVITY 10 38 7.129e-05 0.001656
41 PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING 6 15 0.0001637 0.00371
42 METALLOENDOPEPTIDASE ACTIVITY 18 113 0.0001759 0.00383
43 CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS 10 42 0.0001773 0.00383
44 CYTOKINE ACTIVITY 28 219 0.0001881 0.003972
45 FIBRONECTIN BINDING 8 28 0.000203 0.004191
46 HEPARIN BINDING 22 157 0.0002445 0.004909
47 TRANSFORMING GROWTH FACTOR BETA BINDING 6 16 0.0002484 0.004909
NumGOOverlapSizeP ValueAdj. P Value
1 CELL SUBSTRATE JUNCTION 67 398 3.855e-14 2.251e-11
2 EXTRACELLULAR MATRIX 68 426 3.422e-13 9.384e-11
3 ANCHORING JUNCTION 74 489 4.82e-13 9.384e-11
4 PROTEINACEOUS EXTRACELLULAR MATRIX 58 356 8.198e-12 1.197e-09
5 CHROMOSOME 105 880 3.309e-11 3.865e-09
6 EXTRACELLULAR MATRIX COMPONENT 30 125 7.444e-11 7.245e-09
7 CHROMATIN 62 441 8.275e-10 6.041e-08
8 TRANSCRIPTION FACTOR COMPLEX 48 298 7.733e-10 6.041e-08
9 CELL SURFACE 90 757 1.09e-09 7.072e-08
10 EXTRACELLULAR SPACE 138 1376 4.8e-09 2.803e-07
11 BASEMENT MEMBRANE 22 93 3.288e-08 1.746e-06
12 ENDOPLASMIC RETICULUM LUMEN 34 201 6.712e-08 3.267e-06
13 COMPLEX OF COLLAGEN TRIMERS 10 23 4.021e-07 1.806e-05
14 MEMBRANE MICRODOMAIN 40 288 1.126e-06 4.699e-05
15 CELL JUNCTION 110 1151 2.079e-06 8.094e-05
16 SIDE OF MEMBRANE 51 428 4.38e-06 0.0001599
17 CHROMOSOMAL REGION 42 330 5.994e-06 0.0002059
18 PROTEIN COMPLEX INVOLVED IN CELL ADHESION 10 30 7.109e-06 0.0002306
19 CHROMOSOME CENTROMERIC REGION 27 174 7.902e-06 0.0002429
20 NUCLEAR CHROMATIN 38 291 9.056e-06 0.0002644
21 NUCLEAR CHROMOSOME 57 523 1.848e-05 0.0005139
22 CONDENSED CHROMOSOME 28 195 2.384e-05 0.0006327
23 BANDED COLLAGEN FIBRIL 6 12 3.547e-05 0.0009007
24 COLLAGEN TRIMER 16 88 8.07e-05 0.001964
25 LAMELLIPODIUM MEMBRANE 7 19 8.467e-05 0.001978
26 CYTOSKELETON 160 1967 0.0001115 0.002505
27 KINETOCHORE 19 120 0.0001276 0.00276
28 MHC PROTEIN COMPLEX 8 27 0.0001532 0.002886
29 CONDENSED CHROMOSOME CENTROMERIC REGION 17 102 0.0001502 0.002886
30 EXTERNAL SIDE OF PLASMA MEMBRANE 30 238 0.0001459 0.002886
31 MEMBRANE REGION 100 1134 0.0001491 0.002886
32 MIDBODY 20 132 0.0001595 0.002911
33 INTRINSIC COMPONENT OF PLASMA MEMBRANE 136 1649 0.0002108 0.00373
34 CENTROSOME 50 487 0.0002567 0.00441
35 NUCLEAR PERIPHERY 18 121 0.0004185 0.006984
36 CENTRIOLE 16 102 0.0004713 0.00744
37 PLASMA MEMBRANE RECEPTOR COMPLEX 23 175 0.0004586 0.00744
38 FILOPODIUM MEMBRANE 6 18 0.0005177 0.007956

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 ECM_receptor_interaction_hsa04512 27 82 1.88e-13 9.776e-12
2 Focal_adhesion_hsa04510 39 199 8.793e-11 2.286e-09
3 PI3K_Akt_signaling_pathway_hsa04151 54 352 4.316e-10 7.481e-09
4 Cell_cycle_hsa04110 24 124 4.564e-07 4.726e-06
5 Phagosome_hsa04145 27 152 5.446e-07 4.726e-06
6 TNF_signaling_pathway_hsa04668 22 108 5.453e-07 4.726e-06
7 Cellular_senescence_hsa04218 27 160 1.543e-06 1.146e-05
8 Cell_adhesion_molecules_.CAMs._hsa04514 25 145 2.492e-06 1.509e-05
9 p53_signaling_pathway_hsa04115 16 68 2.613e-06 1.509e-05
10 Regulation_of_actin_cytoskeleton_hsa04810 29 208 3.01e-05 0.0001565
11 Apoptosis_hsa04210 22 138 3.481e-05 0.0001645
12 Cytokine_cytokine_receptor_interaction_hsa04060 33 270 0.0001267 0.0005491
13 Hippo_signaling_pathway_hsa04390 22 154 0.0001847 0.0007388
14 TGF_beta_signaling_pathway_hsa04350 14 84 0.0005602 0.002081
15 MAPK_signaling_pathway_hsa04010 33 295 0.0006418 0.002225
16 Ferroptosis_hsa04216 8 40 0.002607 0.008472
17 FoxO_signaling_pathway_hsa04068 16 132 0.007026 0.02108
18 Hedgehog_signaling_pathway_hsa04340 8 47 0.007295 0.02108
19 Rap1_signaling_pathway_hsa04015 22 206 0.008158 0.02157
20 Notch_signaling_pathway_hsa04330 8 48 0.008295 0.02157
21 Apoptosis_multiple_species_hsa04215 6 33 0.01405 0.03479
22 Wnt_signaling_pathway_hsa04310 16 146 0.01751 0.04138
23 Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 15 139 0.02374 0.05367
24 Hippo_signaling_pathway_multiple_species_hsa04392 5 29 0.03001 0.06503
25 Jak_STAT_signaling_pathway_hsa04630 16 162 0.04096 0.0852
26 ABC_transporters_hsa02010 6 45 0.05573 0.1115
27 Adherens_junction_hsa04520 8 72 0.07341 0.1396
28 Lysosome_hsa04142 12 123 0.07518 0.1396
29 HIF_1_signaling_pathway_hsa04066 10 100 0.08669 0.1554
30 Gap_junction_hsa04540 9 88 0.09044 0.1568
31 cAMP_signaling_pathway_hsa04024 17 198 0.102 0.1711
32 Apelin_signaling_pathway_hsa04371 12 137 0.1363 0.2215
33 Tight_junction_hsa04530 14 170 0.1618 0.255
34 cGMP_PKG_signaling_pathway_hsa04022 13 163 0.2023 0.3094
35 Ras_signaling_pathway_hsa04014 17 232 0.2596 0.3857
36 Endocytosis_hsa04144 17 244 0.3303 0.4771
37 Oocyte_meiosis_hsa04114 9 124 0.3517 0.4943
38 Sphingolipid_signaling_pathway_hsa04071 8 118 0.439 0.5994
39 mTOR_signaling_pathway_hsa04150 10 151 0.4495 0.5994
40 VEGF_signaling_pathway_hsa04370 4 59 0.4939 0.6421
41 Neuroactive_ligand_receptor_interaction_hsa04080 17 278 0.5429 0.6737
42 Phospholipase_D_signaling_pathway_hsa04072 9 146 0.5442 0.6737
43 Mitophagy_animal_hsa04137 4 65 0.5712 0.6908
44 AMPK_signaling_pathway_hsa04152 7 121 0.619 0.7316
45 Necroptosis_hsa04217 9 164 0.6832 0.7895
46 NF_kappa_B_signaling_pathway_hsa04064 5 95 0.7008 0.7922
47 ErbB_signaling_pathway_hsa04012 4 85 0.774 0.8563
48 Calcium_signaling_pathway_hsa04020 9 182 0.7929 0.8589
49 Peroxisome_hsa04146 3 83 0.8914 0.9459
50 Autophagy_animal_hsa04140 3 128 0.9869 1

Quest ID: 33fc1e010e3bdc372edd7dd690945767